The increasing use of normothermic cardiopulmonary
|
|
- Josephine Daniels
- 5 years ago
- Views:
Transcription
1 A Prospective, Randomized Study of Cardiopulmonary Bypass Temperature and Blood Transfusion Paul E. Stensrud, MD, Gregory A. Nuttall, MD, Maria A. de Castro, MD, Martin D. Abel, MD, Mark H. Ereth, MD, William C. Oliver, Jr, MD, Sandra C. Bryant, MS, and Hartzell V. Schaff, MD Departments of Anesthesiology, Surgery, and Biostatistics, Mayo Clinic, Rochester, Minnesota Background. We hypothesized that normothermic cardiopulmonary bypass (CPB) would be associated with decreased blood loss and allogeneic transfusion requirements relative to hypothermic CPB. Methods. After obtaining institutional review board approval and informed patient consent, we conducted a prospective, randomized study of 79 patients undergoing CPB for a primary cardiac operation at normothermic (37 C) (n 44) or hypothermic temperature (25 C) (n 35). Blood loss and transfusion requirements in the operating room and for the first 24 hours in the intensive care unit were determined. A paired t test and rank sum tests were used. A p value of less than 0.05 was considered significant. The increasing use of normothermic cardiopulmonary bypass (CPB) in patients undergoing cardiac operations has initiated a debate concerning the relative risks and benefits of normothermic and hypothermic CPB [1 10]. This debate has spawned a number of clinical studies reporting various measures of outcome, but little information has been published pertaining to differences in blood loss and allogeneic transfusion requirements between normothermic and hypothermic techniques [2 10]. Cardiopulmonary bypass has been demonstrated to be associated with major hemostatic defects arising from exposure of the blood to synthetic nonbiologic surfaces [11, 12]. These defects of hemostasis result in blood loss and frequent transfusion of allogeneic blood products to patients undergoing CPB [13 16]. Hypothermia alone is known to induce platelet dysfunction and inhibit coagulation, which may exacerbate the bleeding when hypothermia is used in conjunction with CPB [6 8]. Patients undergoing CPB are thus at risk for transfusion reaction and transmission of transfusionrelated disease [17 19]. In addition, the higher transfusion requirements place a burden on blood banks and increase the cost of care for these patients. These risks and costs may be increased if hypothermic CPB results in greater blood loss and transfusion requirements. Accepted for publication Sep 3, Address reprint requests to Dr Stensrud, Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905; stensrud.paul@mayo.edu. Results. The normothermic and hypothermic CPB groups did not differ in demographic variables, CPB or cross-clamp duration, heparin sodium or protamine sulfate dose, prothrombin time, or thromboelastogram results. There were no differences between the two CPB groups in blood loss or transfusion requirements. Conclusions. We found that when there was no difference in duration of CPB, normothermic and hypothermic CPB groups demonstrated similar blood loss and transfusion requirements even though other studies have shown hypothermia induces platelet dysfunction and alters the activity of the coagulation cascade. (Ann Thorac Surg 1999;67:711 5) 1999 by The Society of Thoracic Surgeons On the basis of clinical observations, we believed that patients undergoing normothermic CPB bled less than patients undergoing hypothermic CPB. We therefore hypothesized that cardiac surgical procedures using normothermic CPB would be associated with decreased blood loss and transfusion of allogeneic blood products compared with such procedures with hypothermic CPB. Material and Methods After we obtained institutional review board approval and informed patient consent, 79 patients undergoing primary median sternotomy for coronary artery bypass grafting, septal myotomy-myectomy, or single-valve repair or replacement were randomly assigned to receive normothermic (37 C) or hypothermic (25 C) CPB. Exclusion criteria included any antifibrinolytic therapy, weight of less than 45 kg, preoperative hemoglobin level of less than 10 g/dl, preoperative platelet count lower than /mm 3, creatinine value greater than 2.0 mg/dl, preoperative administration of thrombolytic agents, preoperative warfarin sodium therapy, and known history of a bleeding disorder. Preoperative intake of aspirin, di- This article has been selected for the open discussion forum on the STS Web site: by The Society of Thoracic Surgeons /99/$20.00 Published by Elsevier Science Inc PII S (99)
2 712 STENSRUD ET AL Ann Thorac Surg CPB TEMPERATURE AND TRANSFUSION 1999;67:711 5 pyridamole, and nonsteroidal antiinflammatory medications was noted. Intraoperative Management A single surgeon (H.V.S.) operated on all of the patients. A standardized moderate-dose opioid-based anesthesia technique supplemented with benzodiazepines, muscle relaxants, and inhalational anesthetic agents was used. Cardiopulmonary bypass was conducted with a Univox membrane oxygenator (Baxter Healthcare Corp, Bentley Laboratories Division, Irvine, CA) and a Sarns 9000 CPB machine (Sarns Inc, Ann Arbor, MI). The CPB circuit was primed with Plasmalyte, 1.5 L, sodium bicarbonate (NaHCO 3 ), 10 meq, and mannitol, 12.5 g. Porcine heparin was administered to patients as follows: The initial dose consisted of a bolus of 9,000 units body surface area (square meters) and a pump priming dose of 10,000 units. Additional heparin (5,000 units) was administered when the celite activated coagulation time (ACT) was less than 450 seconds (Hemochron 801; International Technidyne, Edison, NJ). After discontinuation of CPB, the initial protamine sulfate dose was mg per unit of heparin administered. Heparin neutralization was considered adequate if the ACT result after protamine was within 10% of the baseline ACT value or, in the case of patients receiving preoperative heparin therapy, if the ACT after protamine was less than 150 seconds. Additional protamine (20 to 50 mg) was administered at the discretion of the attending clinician if the ACT had not returned to this range. Patient temperature was measured with a nasopharyngeal thermistor. Cardiopulmonary bypass temperature was documented as the lowest nasopharyngeal temperature achieved during CPB. Intraoperative autotransfusion and postoperative reinfusion of shed blood were used in all patients. Transfusion criteria for allogeneic blood products were standardized. Red blood cells were administered if the hemoglobin concentration was less than 7 g/dl during CPB and less than 8 g/dl after discontinuation of CPB. Fresh frozen plasma, platelets, or cryoprecipitate was given if the patient demonstrated nonsurgical bleeding, abnormal laboratory studies of hemostasis (thromboelastogram [TEG], platelet count, prothrombin time, activated partial thromboplastin time [aptt], and fibrinogen concentration), or both. Data Collection Preoperative hemoglobin concentration and platelet count were recorded. Activated clotting times were recorded before heparin administration, during CPB, and after heparin neutralization with protamine. Patient temperature was recorded as baseline, minimum temperature during CPB, and temperature on departure from the operating room. After protamine administration and return of ACT to within 10% of baseline, blood was collected for determination of hemoglobin and fibrinogen concentration, platelet count, prothrombin time, aptt, and TEG. Intraoperative blood loss after CPB was estimated by recording the volume of reinfused salvaged red blood Table 1. Perioperative Demographic Characteristics a,b cells, which had been collected in a dedicated suction canister. Drain output was recorded for the first 24 hours postoperatively. Shed mediastinal blood was salvaged and reinfused into the patient for the first 24 hours postoperatively. The amount of allogeneic and autologous red blood cells, platelets, fresh frozen plasma, and cryoprecipitate transfused in the operating room and for the first 24 hours postoperatively was recorded. Statistical Analysis Data were expressed as the median and the range. Wilcoxon rank sum tests were used to compare data between the hypothermic and normothermic groups. A p value of less than 0.05 was considered significant. For the outcome variables, 95% confidence intervals about the median differences between the two groups were based on distribution-free methods in Hollander and Wolfe [20]. Multiple regression modeling was used to assess the effect of temperature on blood loss and amount of blood transfused after adjusting for appropriate covariates. Results Hypothermic (25 C) CPB (n 35) Normothermic (37 C) CPB (n 44) p Value Age (y) 62, , Female sex 11 (31) 13 (30) 1.00 Height (cm) 173, , Weight (kg) 80, , BSA (m 2 ) 2.0, , Preop aspirin 19 (54) 31 (70) 0.16 Preop heparin 6 (17) 16 (36) 0.08 Preop nonsteroidal 1 (3) 3 (7) 0.63 drug Procedure 0.03 CABG 16 (46) 31 (70) Aortic valve repair 9 (26) 2 (5) Mitral valve repair 5 (14) 8 (18) Septal myectomy 3 (9) 1 (2) Other 2 (6) 2 (5) a Where applicable, data are shown as the median and the range. b Numbers in parentheses are percentages. BSA body surface area; CABG coronary artery bypass grafting; CPB cardiopulmonary bypass. The demographic characteristics of the study population are summarized in Table 1. There were no differences in these variables between the two groups, except that a greater percentage of patients in the normothermic group received preoperative heparin therapy ( p 0.08) and had a coronary artery bypass grafting procedure ( p 0.03). Perioperative surgical characteristics are summarized in Table 2. There were no differences between the two groups except the minimal temperature on CPB, temperature on arrival at intensive care unit (ICU), and initial ACT. The minimum patient temperature on CPB and the patient temperature on arrival at the ICU were lower in
3 Ann Thorac Surg STENSRUD ET AL 1999;67:711 5 CPB TEMPERATURE AND TRANSFUSION 713 Table 2. Perioperative Surgical Characteristics a Hypothermic (25 C) CPB (n 35) Normothermic (37 C) CPB (n 44) p Value CPB duration (min) 52, , Aortic cross-clamp duration (min) 34, , Temperature ( C) Initial 35.9, , Minimal on CPB 25, , After CPB 37.3, , On arrival to ICU 36.0, , Initial heparin dose (units) 18,000, 14,000 24,000 18,000, 10,000 25, Protamine dose (mg) 250, , Initial ACT (s) 146, , ACT after protamine (s) 136, , a Data are shown as the median and the range. ACT activated clotting time; CPB cardiopulmonary bypass; ICU intensive care unit. the hypothermic CPB group. The baseline ACT was prolonged in the normothermic CPB group, but this group included a greater number of patients who received heparin infusions preoperatively. The initial temperature was also marginally higher in the normothermic group than in the hypothermic group, although not enough to reach significance ( p 0.08). Blood loss and coagulation test results are summarized in Table 3. There was no difference in perioperative blood loss between The aptt after CPB was prolonged in the hypothermic CPB group. The prothrombin time, platelet count, hemoglobin concentration, and fibrinogen concentrations after CPB did not differ between The amount of blood products transfused in the operating room and the ICU are shown in Figures 1 and 2, respectively. The blood product transfusions were non- Gaussian in distribution, and the results were thus expressed as median and interquartile ranges. There were no significant differences in blood product transfusion between the two groups when analyzed by the Wilcoxon rank sum test. There were no significant differences in either median ICU stay or median hospital stay between Because there were significant differences between the two groups in initial ACT and number of coronary artery bypass grafting procedures and nearly significant differences in preoperative heparin therapy and initial temperature, multiple regression modeling was performed to assess the effect of temperature on blood loss and amount of blood transfused. The dependent variables were intraoperative blood loss, 12-hour blood loss, amount of red blood cells transfused in the operating room, total blood transfused in the operating room, and amount of red blood cells transfused within 12 hours after leaving the operating room. After adjusting for the Table 3. Blood Loss and Coagulation Test Results Hypothermic (25 C) CPB (n 35) a Normothermic (37 C) CPB (n 44) a p Value Median Difference Between Groups (95% CI) Intraop blood loss after CPB (ml) 248, , 88 1, ( 17, 68) 12-Hour ICU blood loss (ml) 725, 410 3, , 195 1, ( 50, 309) Preop hemoglobin (g/dl) 13.8, , ( 1.1, 0.4) Preop platelet count (10 3 /mm 3 ) 217, , ( 31, 27) Hemoglobin after 24 hours in ICU (g/dl) 10.6, , ( 1, 0.5) Intraop PT after CPB (s) 14.3, , ( 0.4, 0.8) Intraop aptt after CPB (s) 39, , (1.2, 8.7) Intraop platelet count after CPB (10 3 /mm 3 ) 124, , ( 25, 20) Intraop fibrinogen after CPB (mg/dl) 191, , ( 22, 15) Thromboelastography R (mm) 15, , ( 0.5, 3.0) Angle (degrees) 49.5, , ( 5, 3) MA (mm) 54, , ( 4, 2.5) MA 60 (mm) 44, , , ( 2, 11) a Data are shown as the median and the range. aptt activated partial thromboplastin time; CI confidence interval; CPB cardiopulmonary bypass; ICU intensive care unit; MA maximal amplitude; MA 60 amplitude 60 minutes after MA; PT prothrombin time; R reaction time.
4 714 STENSRUD ET AL Ann Thorac Surg CPB TEMPERATURE AND TRANSFUSION 1999;67:711 5 Fig 1. Allogeneic transfusion and intraoperative autotransfusion exposures in operating room after cardiopulmonary bypass (CPB) (median and interquartile ranges). Each dot represents 1 patient, and patients who did not receive that blood product are positioned under 0. There were no significant differences in median or mean transfusion requirements between groups. (cryo cryoprecipitate; FFP fresh frozen plasma; RBCs red blood cells.) covariates, there were no significant differences between Comment This prospective, randomized study demonstrated no difference in blood loss or transfusion requirements between a group of patients undergoing normothermic (37 C) CPB and a group having hypothermic (25 C) CPB. Table 3 indicates with 95% certainty that the betweengroup difference in intraoperative blood loss is no greater than 68 ml and 12-hour blood loss, no greater than 309 ml. A recent prospective, randomized study [5] of CPB Fig 2. Allogeneic transfusion exposures in the first 24 hours in intensive care unit (ICU) (median and interquartile ranges). Each dot represents 1 patient, and patients who did not receive that blood product are positioned under 0. There were no significant differences in median or mean transfusion requirements between groups. (cryo cryoprecipitate; FFP fresh frozen plasma; RBCs red blood cells.) temperature and bleeding and transfusion requirements showed the same results. All patients in our study were operated on by a single surgeon (H.V.S.). There was no difference in duration of CPB or aortic cross-clamp time between Anesthesia teams using standardized anesthesia techniques during a defined period of time cared for the patients. Transfusion practices in the operating room and the ICU were standardized. Signal features of this study include a prospective, randomized design, relatively large groups, similar CPB times, and use of the TEG and other coagulation tests to measure global hemostatic function. The intent of this study was to have equal numbers of patients in the normothermic and hypothermic groups. Medical record numbers were used to determine group assignment: even numbers received normothermic CPB and odd numbers, hypothermic CPB. This method of randomization resulted in the group sizes observed. Therefore, power analyses were performed to understand the power of the resulting study. For intraoperative blood loss, this study would have had 90% power to detect a 41% decrease in blood loss in the normothermic group and 80% power to detect a 35% drop in blood loss in the normothermic group. These power estimates were obtained using a pooled standard deviation estimate from both groups and the mean observed in the hypothermic group. Using similar techniques for 12-hour blood loss, similar power results were obtained. This study could have been improved by blinding the anesthesia and surgical personnel to the temperature. However, this would be impractical, as the surgeon might be able to detect the temperature difference in the operative field and the anesthesia team is obliged to monitor the patient s temperature during the surgical procedure. There was a difference in patient temperature on arrival to the ICU, but it was not clinically significant. We might have found different results if there had been a greater difference in patient temperature on arrival to the ICU [13]. ecause random differences were found in preoperative heparin therapy, initial ACT, and initial temperature between the two groups, these covariates along with other significant covariates were included in a multiple regression model to assess the effect of bypass temperature on blood use. One study [16] found previous heparin therapy was a predictor of increased red blood cell transfusions, but other studies [13, 15] reported that preoperative heparin therapy was not a significant determinant of blood transfusion in patients undergoing primary coronary artery bypass procedures. Further, in the recent prospective, randomized study by Dennehy and Nathan [5], there was no difference in preoperative heparin use and no difference in blood loss or transfusion requirements between normothermic and hypothermic groups. The CPB durations were short. We might have seen different results with longer CPB times. Finally, the study included only patients undergoing primary sternotomy and no more than single-valve replacement. Different results might have been noted with patients undergoing repeat sternotomy or more complex surgical procedures.
5 Ann Thorac Surg STENSRUD ET AL 1999;67:711 5 CPB TEMPERATURE AND TRANSFUSION 715 Some groups [7 10] have reported an increase in transfusion requirements in patients undergoing hypothermic CPB relative to those undergoing normothermic CPB. Other studies [3 6] demonstrated no difference in blood loss or transfusion requirements between normothermic and hypothermic CPB groups. In all these negative studies, there were no significant differences in length of CPB. An advantage of normothermic CPB is that it frequently allows shorter CPB durations, as the time to cool and rewarm is obviated [2]. Platelet activation and subsequent dysfunction increase with the duration of CPB. Comparative studies [1, 2, 13] have consistently shown an increased CPB time with hypothermic CPB. Therefore, temperature during CPB may be a less important factor than duration of CPB on blood loss and transfusion requirements. In other words, the effects of the CPB circuit and oxygenator on hemostasis over time appear to be much more important than the effect of temperature. Despite the fact that hypothermia is documented to inhibit platelet and coagulation factor function [6 8], this study demonstrated no difference in TEG results. The absence of difference in the TEG maximal amplitude, a coagulation test that is thought to measure platelet function, may indicate that temperature during CPB had little effect on postoperative platelet function. The TEG maximal amplitude is also affected by fibrinogen concentration and therefore may not be as sensitive as other measures of platelet function, such as bleeding time or platelet aggregometry. The only difference in coagulation test results after CPB between the normothermic and hypothermic groups in this study was a longer aptt in the hypothermic group. The prolonged aptt in this group is consistent with the finding in a previous report [20] of the effect of hypothermia on aptt. Another possible cause of the prolonged aptt after CPB may represent a subtle worsening of hemostatic function in this group that cannot be detected in relatively crude measures of blood loss and transfusion requirement. Blood loss and transfusion requirements are, however, the major outcome variables associated with patient complications and increased cost of care. The results of this study combined with those of earlier studies support the supposition that temperature during CPB may be a less critical determinant of perioperative blood loss and allogeneic transfusion requirements than duration of CPB. In effect, the hemostatic insult imposed by the CPB circuit and oxygenator may be more important than that imposed by hypothermia. In summary, this prospective, randomized study with similar, albeit relatively short, CPB durations demonstrated no difference in blood loss or transfusion requirements between normothermic and hypothermic CPB groups. Supported by the Mayo Foundation for Medical Education and Research. We thank Ms Malinda Woodward, Ms Stacy Hanf, and Ms Kimberly Smith for assistance with manuscript preparation. References 1. The Warm Heart Investigators. Randomised trial of normothermic versus hypothermic coronary bypass surgery. Lancet 1994;343: Christenson JT, Maurice JM, Simonet F, Velebit V, Schmuziger M. Normothermic versus hypothermic perfusion during primary coronary artery bypass grafting. Cardiovasc Surg 1995;3: Yau TM, Carson S, Weisel RD, et al. The effect of warm heart surgery on postoperative bleeding. J Thorac Cardiovasc Surg 1992;103: Nathan HJ, Polis T. The management of temperature during hypothermic cardiopulmonary bypass. II. Effects of prolonged hypothermia. Can J Anaesth 1995;42: Dennehy KC, Nathan HJ. The effect of mild hypothermia on bleeding following coronary artery bypass graft surgery [Abstract]. Anesth Analg 1997;84:S Mazer CD, Hornstein A, Freedman J. Platelet activation in warm and cold heart surgery. Ann Thorac Surg 1995;59: Boldt J, Knothe C, Welters I, Dapper FL, Hempelmann G. Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ? Ann Thorac Surg 1996;62: Boldt J, Knothe C, Zickmann B, Bill S, Dapper F, Hempelmann G. Platelet function in cardiac surgery: influence of temperature and aprotinin. Ann Thorac Surg 1993;55: Tönz M, Mihaljevic T, von Segesser LK, et al. Normothermia versus hypothermia during cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg 1995;59: Arom KV, Emery RW, Northrup WF. Warm heart surgery: a prospective comparison between normothermic and tepid temperature. J Cardiac Surg 1995;10: Khuri SF, Wolfe JA, Josa M, et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992;104: Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76: Despotis GT, Filos KS, Zoys TN, Hogue CW, Spitznagel E, Lappas DG. Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients. Anesth Analg 1996;82: Sanguis Study Group. Use of blood products for elective surgery in 43 European hospitals. Transfusion Med 1994;4: Surgenor DM, Churchill WH, Wallace EL, et al. Determinants of red cell, platelet, plasma, and cryoprecipitate transfusions during coronary artery bypass graft surgery: the Collaborative Hospital Transfusion Study. Transfusion 1996; 36: Ferraris VA, Gildengorin V. Predictors of excessive blood use after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1989;98: Schreiber GB, Busch MP, Kleinman SH, Korelotz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334: Sloand EM, Pitt E, Klein H. Safety of the blood supply. JAMA 1995;274: Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327: Hollander M, Wolf D. Nonparametric statistical methods. New York: John Wiley & Sons, 1973: Staab DB, Sorensen VJ, Fath JJ, et al. Coagulation defects resulting from ambient temperature-induced hypothermia. J Trauma 1994;36:634 8.
TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage
TEG-Directed Transfusion in Complex Cardiac Surgery: Impact on Blood Product Usage Kevin Fleming, CCP; Roberta E. Redfern, PhD; Rebekah L. March, MPH; Nathan Bobulski, CCP; Michael Kuehne, PhD, PA-C; John
More informationCardiopulmonary Support and Physiology
CSP Hemodilution and surgical hemostasis contribute significantly to transfusion requirements in patients undergoing coronary artery bypass Sandra Dial, MD, MSc, Eugene Delabays, MD, Martin Albert, MD,
More informationQuantitative Evaluation of Hypothermia, Hyperthermia, and Hemodilution on Coagulation
The Journal of The American Society of ExtraCorporeal Technology Quantitative Evaluation of Hypothermia, Hyperthermia, and Hemodilution on Coagulation Scott A. Kmiecik, MPS; Jun-Li Liu, MPS, MD, PhD; Tal
More informationHow can ROTEM testing help you in cardiac surgery?
How can ROTEM testing help you in cardiac surgery? Complicated bleeding situations can appear intra and post operatively. They can be life-threatening and always require immediate action. A fast differential
More informationBlood Management of the Cardiac Patient in the Postoperative Period
Blood Management of the Cardiac Patient in the Postoperative Period Al Stammers, MSA, CCP, Eric Tesdahl, PhD Andy Stasko MS, CCP, RRT, Linda Mongero, BS, CCP, Sam Weinstein, MD, MBA Goal To examine the
More informationComparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery
Butler Journal of Undergraduate Research Volume 2 Article 24 2016 Comparison of Tranexamic Acid and Aminocaproic Acid in Coronary Bypass Surgery Lisa K. LeCleir Butler University, lisa.lecleir@gmail.com
More informationThromboelastography Use in the Perioperative Transfusion Management of a Patient with Hemophilia A Undergoing Liver Transplantation
Open Journal of Organ Transplant Surgery, 2013, 3, 13-17 http://dx.doi.org/10.4236/ojots.2013.31003 Published Online February 2013 (http://www.scirp.org/journal/ojots) Thromboelastography Use in the Perioperative
More informationModern Transfusion Management in Cardiovascular Surgery
Modern Transfusion Management in Cardiovascular Surgery Linda Shore-Lesserson, M.D. Professor of Anesthesiology Albert Einstein School of Medicine Montefiore Medical Center Bronx, New York Patient Blood
More informationAdvances in Transfusion and Blood Conservation
Advances in Transfusion and Blood Conservation Arman Kilic, MD Division of Cardiac Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD No relevant financial relationships to disclose.
More informationAdequate hemostasis remains an important issue in
Fresh Frozen Plasma in the Pediatric Pump Prime: A Prospective, Randomized Trial Mary M. McCall, MSN, Mindy M. Blackwell, MS, Jonathan T. Smyre, MS, Joseph J. Sistino, MPA, Jeffrey R. Acsell, BS, B. Hugh
More informationPerioperative disturbances of hemostasis resulting in increased perioperative
Evolving Technology Hofer et al Influence of body core temperature on blood loss and transfusion requirements during off-pump coronary artery bypass grafting: A comparison of 3 warming systems C. K. Hofer,
More informationCABG in the Post-Aprotinin Era: Are We Doing Better? Ziv Beckerman, David Kadosh, Zvi Peled, Keren Bitton-Worms, Oved Cohen and Gil Bolotin
CABG in the Post-Aprotinin Era: Are We Doing Better? Ziv Beckerman, David Kadosh, Zvi Peled, Keren Bitton-Worms, Oved Cohen and Gil Bolotin DISCLOSURES None Objective(s): Our department routinely used
More informationRed Blood Cell Conservation A Surgeon s Journey. Goya V. Raikar MD FACS, FCCP Oklahoma Heart Hospital
Red Blood Cell Conservation A Surgeon s Journey Goya V. Raikar MD FACS, FCCP Oklahoma Heart Hospital Red Blood Cell Conservation Clinical impetus Evidence based learning Program development Industry partnerships
More informationECMO vs. CPB for Intraoperative Support: How do you Choose?
ECMO vs. CPB for Intraoperative Support: How do you Choose? Shaf Keshavjee MD MSc FRCSC FACS Director, Toronto Lung Transplant Program Surgeon-in-Chief, University Health Network James Wallace McCutcheon
More informationIntra-operative Effects of Cardiac Surgery Influence on Post-operative care. Richard A Perryman
Intra-operative Effects of Cardiac Surgery Influence on Post-operative care Richard A Perryman Intra-operative Effects of Cardiac Surgery Cardiopulmonary Bypass Hypothermia Cannulation events Myocardial
More informationAcute Kidney Injury after Cardiac Surgery: Incidence, Risk Factors and Prevention
Acute Kidney Injury after Cardiac Surgery: Incidence, Risk Factors and Prevention Hong Liu, MD Professor of Clinical Anesthesiology Department of Anesthesiology and Pain Medicine University of California
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationReinfusion of autologous blood after cardiac surgery
Safety and Efficacy of Perioperative Cell Salvage and After Coronary Artery Bypass Grafting: A Randomized Trial Gavin J. Murphy, MD, FRCS, Simon M. Allen, FRCS, Jonathon Unsworth-White, FRCS, C. Terence
More informationWithin coronary patients, those who are affected by
The Role of Antithrombin III in the Perioperative Management of the Patient With Unstable Angina Marco Rossi, MD, Lorenzo Martinelli, MD, Sergio Storti, MD, Michele Corrado, MD, Roberto Marra, MD Carmelita
More informationBleeding, Coagulopathy, and Thrombosis in the Injured Patient
Bleeding, Coagulopathy, and Thrombosis in the Injured Patient June 7, 2008 Kristan Staudenmayer, MD Trauma Fellow UCSF/SFGH Trauma deaths Sauaia A, et al. J Trauma. Feb 1995;38(2):185 Coagulopathy is Multi-factorial
More informationTransfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
More informationConventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury?
Conventional CABG Or On Pump Beating Heart: A Difference In Myocardial Injury? Kornelis J. Koopmans Medical Center Leeuwarden Leeuwarden, The Netherlands I have no disclosures Disclosures Different techniques
More informationHemodialysis (HD) has improved the prospects of. Sonoclot Analysis in Cardiac Surgery in Dialysis- Dependent Patients
CARDIOVASCULAR Sonoclot Analysis in Cardiac Surgery in Dialysis- Dependent Patients Toshihiko Shibata, MD, PhD, Yasuyuki Sasaki, MD, PhD, Koji Hattori, MD, PhD, Hidekazu Hirai, MD, Mitsuharu Hosono, MD,
More informationPredictive Model for Blood Product Use in Coronary Artery Bypass Grafting
ORIGINAL ARTICLE Predictive Model for Blood Product Use in Coronary Artery Bypass Grafting Hasanat Sharif, Hamza Zaheer Ansari, Awais Ashfaq, Wasiq Faraz Rawasia, Gulshan Bano and Shiraz Hashmi ABSTRACT
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationHydroxyethyl starch and bleeding
Hydroxyethyl starch and bleeding Anders Perner Dept. of Intensive Care, Rigshospitalet University of Copenhagen Scandinavian Critical Care Trials Group Intensive Care Medicine COIs Ferring, LFB - Honoraria
More informationUniversity of Bristol - Explore Bristol Research
Rogers, C., Capoun, R., Scott, L., Taylor, J., Angelini, G., Narayan, P.,... Ascione, R. (2017). Shortening cardioplegic arrest time in patients undergoing combined coronary and valve surgery: results
More informationHemorrhagic complications of cardiac surgery represent
Factor V Leiden Protects Against Blood Loss and Transfusion After Cardiac Surgery Brian S. Donahue, MD, PhD; David Gailani, MD; Michael S. Higgins, MD, MPH; Davis C. Drinkwater, MD; Alfred L. George, Jr,
More informationNavigating the Dichotomies Between Literature and Your Clinical Practice
Navigating the Dichotomies Between Literature and Your Clinical Practice Robert Groom, CCP, FPP Cardiovascular Institute at Maine Medical Center Disclosures No relevant conflicts related to this presentation
More informationSafety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement
Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement Kevin L. Greason, MD, Lars Englberger, MD, Rakesh M. Suri, MD, PhD, Soon J. Park, MD, Charanjit S. Rihal,
More informationAN AUDIT OF BLOOD PRODUCTS USAGE in adult cardiac surgery at CMJAH/WITS towards minimal or zero blood usage SM MOGALADI 10/11/2017 SAHA SANDTON
AN AUDIT OF BLOOD PRODUCTS USAGE in adult cardiac surgery at CMJAH/WITS towards minimal or zero blood usage SM MOGALADI 10/11/2017 SAHA SANDTON CONVETION CENTRE PREAMBLE Blood products- limited, expensive
More informationIMPROVE PATIENT OUTCOMES AND SAFETY IN ADULT CARDIAC SURGERY.
Clinical Evidence Guide IMPROVE PATIENT OUTCOMES AND SAFETY IN ADULT CARDIAC SURGERY. With the INVOS cerebral/somatic oximeter An examination of controlled studies reveals that responding to cerebral desaturation
More informationTransfusion Requirements and Management in Trauma RACHEL JACK
Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension
More informationIncidence of Postoperative Atrial Fibrillation after minimally invasive mitral valve surgery
Incidence of Postoperative Atrial Fibrillation after minimally invasive mitral valve surgery JUAN S. JARAMILLO, MD Cardiovascular Surgery Clinica CardioVID Medellin Colombia DISCLOSURE INFORMATION Consultant
More informationTRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006
TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 CTU blood product transfusion guidelines 2006 1 Summary of guidelines RED CELLS (10-15ml/kg) This applies to ward patients / icu patients who are stable.
More informationTechnique Article. Jeffrey B. Riley;* Gregory J. Schears; Gregory A. Nuttall; William C. Oliver, Jr.; Mark H. Ereth; Joseph A.
The Journal of ExtraCorporeal Technology Technique Article Coagulation Parameter Thresholds Associated with Non-Bleeding in the Eighth Hour of Adult Cardiac Surgical Post-Cardiotomy Extracorporeal Membrane
More informationCardiothoracic Fellow Expectations Division of Cardiac Anesthesia, Beth Israel Deaconess Medical Center
The fellowship in Cardiothoracic Anesthesia at the Beth Israel Deaconess Medical Center is intended to provide the foundation for a career as either an academic cardiothoracic anesthesiologist or clinical
More informationGUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS
CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.
More informationCardiac surgery is associated with a high incidence of
Retrograde Autologous Priming of the Cardiopulmonary Bypass Circuit Reduces Blood Transfusion After Coronary Artery Surgery Subramaniam Balachandran, FRCA, Michael H. Cross, FRCA, Sivagnanam Karthikeyan,
More informationChallenges in Perioperative. Coagulopathy in Elective and Urgent Cardiac Surgery
Challenges in Perioperative Hemostasis: Managing Coagulopathy in Elective and Urgent Cardiac Surgery Ian J. Welsby, MD, MBBS, FRCA Assistant Professor Department of Anesthesiology and Critical Care Duke
More informationIntra-operative Echocardiography: When to Go Back on Pump
Intra-operative Echocardiography: When to Go Back on Pump GREGORIO G. ROGELIO, MD., F.P.C.C. OUTLINE A. Indications for Intraoperative Echocardiography B. Role of Intraoperative Echocardiography C. Criteria
More informationPRACTICE guidelines are systematically developed recommendations that assist the
Embargoed for release until approved by ASA House of Delegates. No part of this document may be released, distributed or reprinted until approved. Any unauthorized copying, reproduction, appropriation
More informationAbsolute Cerebral Oximeters for Cardiovascular Surgical Cases
Absolute Cerebral Oximeters for Cardiovascular Surgical Cases Mary E. Arthur, MD, Associate Professor, Anesthesiology and Perioperative Medicine Medical College of Georgia at Georgia Regents University
More informationCCAS CPB Workshop Curriculum Outline Perfusion: What you might not know
CCAS CPB Workshop Curriculum Outline Perfusion: What you might not know Scott Lawson, CCP Carrie Striker, CCP Disclosure: Nothing to disclose Objectives: * Demonstrate how the cardiopulmonary bypass machine
More informationExcessive Bleeding After Cardiac Surgery in Adults: Reasons and Management
DOI: 10.2478/v10163-010-0017-2 ACTA CHIRURGICA LATVIENSIS 2009 (9 ) PROBLEM SOLVING ARTICLE Excessive Bleeding After Cardiac Surgery in Adults: Reasons and Management Agnese Ozolina*, Eva Strike*,**,Vladimirs
More informationTransfusion and Blood Conservation
Transfusion and Blood Conservation Kenneth G. Shann, CCP Assistant Director, Perfusion Services Senior Advisor, Performance Improvement Department of Cardiovascular and Thoracic Surgery Montefiore Medical
More informationPostoperative hypothermia and patient outcomes after elective cardiac surgery
doi:10.1111/j.1365-2044.2011.06784.x ORIGINAL ARTICLE Postoperative hypothermia and patient outcomes after elective cardiac surgery D. Karalapillai, 1 D. Story, 2 G. K. Hart, 3,4 M. Bailey, 5 D. Pilcher,
More informationWELCOME. Evaluation Summary
WELCOME Evaluation Summary 489 delegates from 40 countries Delegate s specialty 239 respondents Delegate s professional activity 208 respondents Overall Evaluation This symposium was helpful for your clinical
More informationBlood Transfusion Guidelines in Clinical Practice
Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi
More informationPreparing for Patients at High Risk of Transfusion
18/10/2017 Preparing for Patients at High Risk of Transfusion Jane Ottens. B.Sc., CCP ( Aust) Ashford Hospital, South Australia Preparing for Patients at High Risk of Transfusion Jane Ottens. B.Sc., CCP
More informationThinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease
Thinking outside of the box Perfusion management and myocardial protection strategy for a patient with sickle cell disease Shane Buel MS, RRT 1 Nicole Michaud MS CCP PBMT 1 Rashid Ahmad MD 2 1 Vanderbilt
More informationDo Heparinase Thrombelastographs Predict Postoperative Bleeding?
Original Article Do Heparinase Thrombelastographs Predict Postoperative Bleeding? Paulla Mashburn BS, Jodie Ecklund BS, CCP, Jeffrey Riley BA, CCT, CCP Program in Extracorporeal Circulation Technology,
More informationUse of Recombinant Factor VIIa (NovoSeven) in Pediatric Cardiac Surgery
The Journal of ExtraCorporeal Technology Use of Recombinant Factor VIIa (NovoSeven) in Pediatric Cardiac Surgery Scott D. Niles, BA, CCP;* Harold M. Burkhart, MD;* David A. Duffey, BS, BSN, CCP;* Keri
More informationThe Effects of Cardiopulmonary Bypass with Hollow Fiber Membrane Oxygenator on Blood Clotting Measured by Thromboelastography
Physiol. Res. 51: 145-150, 2002 The Effects of Cardiopulmonary Bypass with Hollow Fiber Membrane Oxygenator on Blood Clotting Measured by Thromboelastography M. HORÁČEK, K. CVACHOVEC Department of Anesthesiology
More informationShock and Resuscitation: Part II. Patrick M Reilly MD FACS Professor of Surgery
Shock and Resuscitation: Part II Patrick M Reilly MD FACS Professor of Surgery Trauma Patient 1823 / 18 Police Dropoff Torso GSW Lower Midline / Right Buttock Shock This Monday Trauma Patient 1823 / 18
More informationLow Dose versus High Dose Heparinization during Post Cardiotomy ECMO: A Case Control Study Disclosures Introduction
Low Dose versus High Dose Heparinization during Post Cardiotomy ECMO: A Case Control Study Vanessa Arnold, BS Mindy M Blackwell, MS, CCP Perfusion Technology Program College of Health Sciences Rush University
More informationDiagnostic, Technical and Medical
Diagnostic, Technical and Medical Approaches to Reduce CABG Related Stroke Pieter Kappetein, Michael Mack, M.D. Dept Thoracic Surgery, Rotterdam, The Netherlands Baylor Healthcare System Dallas, TX Background
More information2012, Görlinger Klaus
Gerinnungsmanagement der Gegenwart - wie gehen wir heute vor? 25. Allander Gerinnungsrunde am 15. März 2012 Klaus Görlinger Universitätsklinikum Essen klaus@goerlinger.net CSL Behring GmbH Octapharma AG
More informationDoes the Use of Ultrafiltration Increase the Risk of Post-Operative Acute Kidney Injury? A Multi-Center Analysis
Does the Use of Ultrafiltration Increase the Risk of Post-Operative Acute Kidney Injury? A Multi-Center Analysis Gordon R. DeFoe, CCP, John Pieroni, CCP, Craig S. Warren, CCP, Charles F. Krumholz, CCP,
More informationCoagulopathy: Measuring and Management. Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine
Coagulopathy: Measuring and Management Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine No Financial Disclosures Objectives Define coagulopathy of trauma Define
More informationPBM: The Future of Transfusion December 6 th 2012 East of England RTC. Sue Mallett Royal Free London NHS Foundation Trust
PBM: The Future of Transfusion December 6 th 2012 East of England RTC Sue Mallett Royal Free London NHS Foundation Trust Patient Blood Management The 3 Pillars Pre-operative optimization of anaemia Minimizing
More informationThe Thromboelastogram and its Applications
Raja, Huening, Bradford, Lamphere November 2013 The Thromboelastogram and its Applications Overview: Blood products administration is an intravenous tissue transplant, in that cells or acellular components
More informationMulti-targeted Antithrombotic Therapy for Total Artificial Heart Device Patients: a case series
Multi-targeted Antithrombotic Therapy for Total Artificial Heart Device Patients: a case series Angeleah Ramirez BS 1 Jeff Riley CCP Lyle Joyce MD 1. Second year perfusion student - Midwestern University
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Table S1: Number and percentage of patients by age category Distribution of age Age
More informationIntraoperative application of Cytosorb in cardiac surgery
Intraoperative application of Cytosorb in cardiac surgery Dr. Carolyn Weber Heart Center of the University of Cologne Dept. of Cardiothoracic Surgery Cologne, Germany SIRS & Cardiopulmonary Bypass (CPB)
More informationCardiopulmonary Support and Physiology
Cardiopulmonary Support and Physiology Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: A prospective, randomized, double-blind, placebo-controlled study Valter Casati, MD a Luca
More informationIs the patient at risk for blood loss of 1000 mls? Avoid these Guidelines. Avoid these Guidelines. Yes. Yes. Yes. Yes. Yes
Clinical Guidelines Acute rmovolemic Hemodilution Guidelines for Cardiac Surgery Department of Anesthesiology and Perioperative Medicine Date: 12-30-2012 Is the patient at risk for blood loss of 1000 mls?
More informationIntraoperative Autologous Blood Donation Preserves Red Cell Mass But Does Not Decrease Postoperative Bleeding
Intraoperative Autologous Blood Donation Preserves Red Cell Mass But Does Not Decrease Postoperative Bleeding Robert E. Helm, MD, John D. Klemperer, MD, Todd K. Rosengart, MD, Jeffrey P. Gold, MD, Powers
More informationFresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation
Fresh and Citrated Whole-Blood Specimens Can Produce Different Thromboelastography Results in Patients on Extracorporeal Membrane Oxygenation Elizabeth A. Gilman, MD, 1 Christopher D. Koch, 1 Paula J.
More informationMajor Haemorrhage Protocol. Commentary
Hairmyres Hospital Monklands Hospital Wishaw General Hospital Major Haemorrhage Protocol Commentary N.B. There is a separate NHSL protocol for the Management of Obstetric Haemorrhage Authors Dr Tracey
More informationGoing on Bypass. What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia
Going on Bypass What happens before, during and after CPB. Perfusion Dept. Royal Children s Hospital Melbourne, Australia Circulation Brain Liver Kidneys Viscera Muscle Skin IVC, SVC Pump Lungs R.A. L.V.
More informationSince its introduction by Salerno and colleagues [1]
Randomized Trial of Intermittent Antegrade Warm Blood Versus Cold Crystalloid Cardioplegia Luc M. Jacquet, MD, Philippe H. Noirhomme, MD, Michel J. Van Dyck, MD, Gebrin A. El Khoury, MD, Amin J. Matta,
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Petričević M., Biočina B., Boban M., Zrno Mihaljević M., White A., Rotim C., Subašić A., Miličić Davor. (2015) Clinical relevance and practical value of platelet function
More informationRequirement in Coronary Bypass Surgery
Blood Loss and Bank Blood Requirement in Coronary Bypass Surgery Thomas Yeh, Jr., Larry Shelton, C.C.P., and Thomas J. Yeh, M.D. ABSTRACT With the use of nonblood prime and refinement in perfusion and
More informationThe Efficacy of Low Prime Volume Completely Closed Cardiopulmonary Bypass in Coronary Artery Revascularization
Original Article The Efficacy of Low Prime Volume Completely Closed Cardiopulmonary Bypass in Coronary Artery Revascularization Hideaki Takai, MD, Kiyoyuki Eishi, MD, Shiro Yamachika, MD, Shiro Hazama,
More informationPractice Guidelines for Perioperative Blood Management
Practice Guidelines for Perioperative Blood Management An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management* P RACTICE guidelines are systematically
More informationLow Oxygen Delivery as a Predictor of Acute Kidney Injury during Cardiopulmonary Bypass
The Journal of ExtraCorporeal Technology Original Articles Low Oxygen Delivery as a Predictor of Acute Kidney Injury during Cardiopulmonary Bypass Richard F. Newland, BSc, CCP; Robert A. Baker, PhD, CCP
More informationContinuing improvement in surgical technique, cardiopulmonary
Stroke After Coronary Artery Bypass Grafting Robert A. Baker, PhD, Lisa J. Hallsworth, BPsych(Hons), and John L. Knight, FRACS Cardiac Surgical Research Group, Cardiac and Thoracic Surgery, Flinders Medical
More informationPractice Guidelines for Perioperative Blood Management
Practice Guidelines for Perioperative Blood Management An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management* P RACTICE guidelines are systematically
More informationCARDIAC ANESTHESIA BLOCK
CARDIAC ANESTHESIA BLOCK THE ROYAL COLLEGE OF PHYSICIANS AND SURGEONS OF CANADA Objectives of Training and Specialty Training Requirements in Anesthesia OVERALL GOALS Specific Objectives in CanMEDS Format
More informationRecombinant Activated Factor VII: Useful. Department of Surgery Grand Rounds 11/8/10 David Mauchley MD
Recombinant Activated Factor VII: Useful Department of Surgery Grand Rounds 11/8/10 David Mauchley MD Hemostasis and Coagulation Traditional cascade model Two convergent pathways Series of proteolytic
More informationHemostasis and thrombosis in patients with liver disease. Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands
Hemostasis and thrombosis in patients with liver disease Ton Lisman, Dept Surgery, UMC Groningen, The Netherlands Importance of the liver in hemostasis Synthesis of Coagulation factors Fibrinolytic proteins
More informationEvaluation of Biocompatible Cardiopulmonary Bypass Circuit Use During Pediatric Open Heart Surgery
The Journal of The American Society of Extra-Corporeal Technology Evaluation of Biocompatible Cardiopulmonary Bypass Circuit Use During Pediatric Open Heart Surgery Joseph Deptula, MPS, CCP; Kimberly Glogowski,
More informationInstitute of Medical Epidemiology, Biostatistics, and Informatics, University of Halle-Wittenberg, Halle (Saale) 2
Do Randomized and Non-Randomized Trials Yield Different Answers in Similar Populations? Evidence from a 'Meta-Propensity Score' Analysis in Cardiac Surgery Kuss O 1, Legler T 1, Börgermann J 2 1 Institute
More informationPreoperative anemia Common, consequential and correctable in non-emergent surgery By Kathrine Frey, MD
Preoperative anemia Common, consequential and correctable in non-emergent surgery By Kathrine Frey, MD Preoperative anemia is common, especially in patients undergoing nonemergent high-blood-loss surgical
More informationMASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE
MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE CONTENTS Definition Indications Transfusion trigger Massive transfusion protocol Complications DEFINITION Massive transfusion:
More informationMinimally Invasive Mitral Valve Repair: Indications and Approach
Minimally Invasive Mitral Valve Repair: Indications and Approach Juan P. Umaña, M.D. Chief Medical Officer Director, Cardiovascular Medicine FCI - Institute of Cardiology Bogota Colombia 1 Mitral Valve
More informationMaterials and Methods
Anesthesiology 2003; 99:42 7 2003 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Large-dose Hydroxyethyl Starch 130/0.4 Does Not Increase Blood Loss and Transfusion Requirements
More informationCardiac surgery and acute kidney injury: retrospective study
Cardiac surgery and acute kidney injury: retrospective study Department of Cardiovascular and Thoracic Surgery University of Liege Hospital (ULg CHU), Belgium MG LAGNY 1, F BLAFFART 1, JO DEFRAIGNE 2,
More informationIncreased postoperative blood loss after cardiac operations
Efficacy of Aprotinin, Epsilon Aminocaproic Acid, or Combination in Cyanotic Heart Disease Sandeep Chauhan, MD, Bisoi Akshay Kumar, MCh, Beeraka Heramba Rao, MD, Marigaddi Sanjeeva Rao, MCh, Bharat Dubey,
More informationMANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY
MANAGEMENT OF COAGULOPATHY AFTER TRAUMA OR MAJOR SURGERY 19th ANNUAL CONTROVERSIES AND PROBLEMS IN SURGERY Thabo Mothabeng General Surgery: 1 Military Hospital HH Stone et al. Ann Surg. May 1983; 197(5):
More informationThe Relationship between Intra-Operative Transfusions and Nadir Hematocrit on Post-Operative Outcomes after Cardiac Surgery
The Journal of ExtraCorporeal Technology The Relationship between Intra-Operative Transfusions and Nadir Hematocrit on Post-Operative Outcomes after Cardiac Surgery Joshua B. Goldberg, MD;* Kenneth G.
More informationAlternative Anticoagulation during Cardiovascular Procedures in Pediatric Patients with Heparin-Induced Thrombocytopenia
The Journal of ExtraCorporeal Technology Alternative Anticoagulation during Cardiovascular Procedures in Pediatric Patients with Heparin-Induced Thrombocytopenia I. Ricardo Argueta-Morales, MD; Monica
More informationThe prevalence of permanent cardiac pacing after. Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers
Permanent Cardiac Pacing After a Cardiac Operation: Predicting the Use of Permanent Pacemakers Richard S. Gordon, BSc, Joan Ivanov, MSc, Gideon Cohen, MD, and Anthony L. Ralph-Edwards, MD Division of Cardiovascular
More informationEffective Date: Approved by: Laboratory Director, Jerry Barker (electronic signature)
1 of 5 Policy #: 702 (PHL-702-05) Effective Date: 9/30/2004 Reviewed Date: 8/1/2016 Subject: TRANSFUSION GUIDELINES Approved by: Laboratory Director, Jerry Barker (electronic signature) Approved by: Laboratory
More informationPROTAMINE IS USED to reverse heparin after termination
A Pharmacokinetic Model for Protamine Dosing After Cardiopulmonary Bypass Michael I. Meesters, MD,* Dennis Veerhoek, CCP, Jan R. de Jong, MD,* and Christa Boer, PhD* Objective: This study investigated
More informationEMSS17: Bleeding patients course material
EMSS17: Bleeding patients course material Introduction During the bleeding patients workshop at the Emergency Medicine Summer School 2017 (EMSS17) you will learn how to assess and treat bleeding patients
More informationAnalysis of Mortality Within the First Six Months After Coronary Reoperation
Analysis of Mortality Within the First Six Months After Coronary Reoperation Frans M. van Eck, MD, Luc Noyez, MD, PhD, Freek W. A. Verheugt, MD, PhD, and Rene M. H. J. Brouwer, MD, PhD Departments of Thoracic
More informationAutotransfusion After Coronary Artery Bypass Grafting Halves the Number of Patients Needing Blood Transfusion
Autotransfusion After Coronary Artery Bypass Grafting Halves the Number of Patients Needing Blood Transfusion Henrik Schmidt, MD, Poul Erik Mortensen, MD, Soren Lars Folsgaard, MD, and Esther A. Jensen,
More informationPatient Blood Management Are you providing this? Jeannie Callum, BA, MD, FRCPC Associate Professor, University of Toronto
Patient Blood Management Are you providing this? Jeannie Callum, BA, MD, FRCPC Associate Professor, University of Toronto Disclosures Relevant relationships with commercial entities: Octapharma, CSL Behring
More information